, Singapore
987 views
/Piasupuntongpool from Envato

Manulife unveils plans with up to 400% critical illness payouts

One of its plans covers 126 critical illnesses and conditions.

Manulife Singapore has introduced two new insurance options to address concerns over serious illnesses.

The Manulife Early CompleteCare (MECC) plan provides coverage for 126 critical illness conditions across all stages, whilst the Manulife EarlyCancer Protect (MECP) plan offers affordable term coverage for all stages of cancer. 

MECC offers a full payout of the sum insured upon diagnosis of any critical illness. 

It also includes features such as a Continuous Cancer Income option, which provides monthly payouts of 4% of the sum insured for up to 60 months, potentially reaching 240% of the insured amount. 

Additionally, its Cover Me Again benefit allows up to four extra critical illness claims, totalling 400% of the sum insured, whilst its Recurring Major Critical Illness benefit provides additional coverage for specific recurring conditions, up to 200% of the sum insured. 

The plan also guarantees a death benefit of at least eight times the annual premium. It covers all stages of cancer and offers a 100% payout upon diagnosis or death.
 

Join Singapore Business Review community

Follow the link s for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.